Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

This activity was originally broadcast in conjunction with AMCP 2025.

Program Description

Schizophrenia is a complex psychiatric disorder that can significantly impact patients, families, and health care systems. Despite improvements in treatments, many standard therapies still have limitations, with only half of patients able to lead normal lives. Novel therapeutic targets and approaches are needed to address negative symptoms and cognitive dysfunction. Disparities persist in management, leading to variations in care quality and patient outcomes. Managed care professionals need to integrate new classes of medications to address unmet needs and ensure timely and equitable access while advancing the standard of care for individuals living with schizophrenia. This program will explore the evolving understanding of the symptomatology and disease burden of schizophrenia, while highlighting recent innovations in treatment as well as challenges in management and its economic impact.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: April 8, 2025
Expiration date: April 8, 2026

Time to complete activity: 1.5 hours

Learner level: Foundational, Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explore the epidemiology and the unmet needs affecting the lifelong management of patients with schizophrenia.
• Analyze recent clinical data on novel treatment approaches for schizophrenia.
• Apply managed care strategies to optimally integrate novel treatment strategies within the treatment paradigm of schizophrenia care.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-25-081-H01-P. The activity is available for CE credit through April 8, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Megan J. Ehret, PharmD, MS, BCPP; Catherine E. Cooke, PharmD, MS, BCPS, PAHM

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms